Alexey Vinogradov
Directeur/Bestuurslid bij XENETIC BIOSCIENCES, INC.
Vermogen: 72 848 $ op 31-05-2024
Actieve functies van Alexey Vinogradov
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
XENETIC BIOSCIENCES, INC. | Directeur/Bestuurslid | 19-07-2019 | - |
Independent Dir/Board Member | 19-07-2019 | - | |
PHARMSYNTHEZ | Directeur/Bestuurslid | 03-08-2023 | - |
Avelas Biosciences, Inc.
Avelas Biosciences, Inc. Medical/Nursing ServicesHealth Services Avelas Biosciences, Inc. develops integrated suite of therapeutic and imaging agents for treatment of cancer. It develops AVB-620, an intravenously administered in vivo fluorescent protease activatable peptide that detects, marks, and diagnoses cancer. The company was founded by Yon Chien Tsien, Quyen T. Nguyen and Michael A. Whitney in 2008 and is headquartered in La Jolla, CA. | Directeur/Bestuurslid | 14-03-2017 | - |
Cantreva LLC | Operationeel Directeur | 01-09-2017 | - |
Loopbaan van Alexey Vinogradov
Eerdere bekende functies van Alexey Vinogradov
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
Togas Middle East LLC | Corporate Officer/Principal | 01-05-2015 | 01-05-2017 |
Togas Group LLC | Corporate Officer/Principal | 01-03-2012 | 01-11-2016 |
ARGOS THERAPEUTICS, INC. | Directeur/Bestuurslid | 06-02-2014 | 10-06-2016 |
Independent Dir/Board Member | 06-02-2014 | 10-06-2016 | |
Bioprocess Capital Partners Ltd.
Bioprocess Capital Partners Ltd. Investment ManagersFinance Bioprocess Capital Partners Ltd (BCP) is a venture capital firm founded in 2006. The firm is headquartered in Moscow, Russia. | Private Equity Investor | 31-12-2010 | 31-12-2010 |
Pharmstandard Ventures
Pharmstandard Ventures Investment ManagersFinance Pharmstandard Ventures (Pharmstd Ventures) is a venture capital subsidiary of Pharmstandard PJSC headquartered in Moscow, Russia. The firm was founded in 2013 by Dr. Andrey Petrov. | Algemeen Directeur | 01-01-2012 | - |
Corporate Officer/Principal | 01-01-2012 | - |
Opleiding van Alexey Vinogradov
Moscow State University Lomonosov | Doctorate Degree |
Statistieken
Internationaal
Rusland | 7 |
Verenigde Staten | 4 |
Verenigde Arabische Emiraten | 2 |
Operationeel
Director/Board Member | 4 |
Corporate Officer/Principal | 3 |
Independent Dir/Board Member | 2 |
Sectoraal
Health Technology | 4 |
Finance | 3 |
Consumer Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Beursgenoteerde bedrijven | 2 |
---|---|
XENETIC BIOSCIENCES, INC. | Health Technology |
PHARMSYNTHEZ | Health Technology |
Bedrijven in privébezit | 7 |
---|---|
Bioprocess Capital Partners Ltd.
Bioprocess Capital Partners Ltd. Investment ManagersFinance Bioprocess Capital Partners Ltd (BCP) is a venture capital firm founded in 2006. The firm is headquartered in Moscow, Russia. | Finance |
Pharmstandard Ventures
Pharmstandard Ventures Investment ManagersFinance Pharmstandard Ventures (Pharmstd Ventures) is a venture capital subsidiary of Pharmstandard PJSC headquartered in Moscow, Russia. The firm was founded in 2013 by Dr. Andrey Petrov. | Finance |
Argos Therapeutics, Inc.
Argos Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Argos Therapeutics, Inc. was a biopharmaceutical company. It engages in development and commercialization of individualized immunotherapies for the treatment of cancer and infectious diseases based on its proprietary technology platform called Arcelis. The firm's product include AGS-003 for the treatment of metastatic renal cell carcinoma, and other cancers; and AGS-004 for the treatment of human immunodeficiency virus. The company was founded by Bruce A. Sullenger, Eli Gilboa, John A. Irick and Ralph M. Steinman on May 8, 1997 and was headquartered in Durham, NC. | Health Technology |
Avelas Biosciences, Inc.
Avelas Biosciences, Inc. Medical/Nursing ServicesHealth Services Avelas Biosciences, Inc. develops integrated suite of therapeutic and imaging agents for treatment of cancer. It develops AVB-620, an intravenously administered in vivo fluorescent protease activatable peptide that detects, marks, and diagnoses cancer. The company was founded by Yon Chien Tsien, Quyen T. Nguyen and Michael A. Whitney in 2008 and is headquartered in La Jolla, CA. | Health Services |
Cantreva LLC | |
Togas Middle East LLC | |
Togas Group LLC |
- Beurs
- Insiders
- Alexey Vinogradov
- Ervaring